ArticleDiscover oncology2024

Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females.

Xiaoning Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.